schizandrin b has been researched along with Cancer of Lung in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 4 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, J; Huang, Y; Luo, J; Luo, X; Tan, T; Wang, N; Wang, Y; Wei, M; Yang, S; Ye, C; Zhang, J | 1 |
| Bi, XJ; Cai, F; Fu, M; He, SY; Jia, LQ; Jing, M; Kong, L; Li, XT; Liu, JJ; Liu, XZ; Yao, XM; Zhang, L | 1 |
| Cai, FY; Fu, M; He, SY; Jing, M; Ju, RJ; Kong, L; Li, XT; Liu, JJ; Liu, XZ; Yao, XM; Zhang, L | 1 |
| Fei, Y; Hai-Zhen, C; Jiang-Pei, S; Jun-Yi, S; Nian-Ping, F; Xiao-Yan, GU; Xing-Mei, X; Ying, L; Zi-Fei, J | 1 |
4 other study(ies) available for schizandrin b and Cancer of Lung
| Article | Year |
|---|---|
Schisandrin B suppresses osteosarcoma lung metastasis
Topics: Animals; Antineoplastic Agents; Apoptosis; beta Catenin; Bone Neoplasms; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cyclooctanes; Disease Models, Animal; Humans; Lignans; Lung Neoplasms; Mice; Osteosarcoma; Phosphatidylinositol 3-Kinases; Polycyclic Compounds; Proto-Oncogene Proteins c-akt; Wnt Signaling Pathway | 2022 |
Enhanced antitumor efficacy using epirubicin and schisandrin B co-delivery liposomes modified with PFV via inhibiting tumor metastasis.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Cell Movement; Chick Embryo; Chorioallantoic Membrane; Cyclooctanes; Epirubicin; Female; Humans; Lignans; Liposomes; Lung Neoplasms; Mice; Neoplasm Invasiveness; Polycyclic Compounds; Xenograft Model Antitumor Assays | 2020 |
Enhanced antitumour efficacy of functionalized doxorubicin plus schisandrin B co-delivery liposomes via inhibiting epithelial-mesenchymal transition.
Topics: Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cyclooctanes; Doxorubicin; Epithelial-Mesenchymal Transition; Humans; Lignans; Liposomes; Lung Neoplasms; Polycyclic Compounds; Vascular Endothelial Growth Factor A | 2021 |
[Preparation and evaluation of schisandrin B-loaded F127 modified lipid-polymer nanoparticles for inhibition of breast cancer lung metastasis].
Topics: Animals; Cyclooctanes; Lignans; Lipids; Lung Neoplasms; Mice; Nanoparticles; Polycyclic Compounds; Polyethylenes; Polymers; Polypropylenes; Rats; Swine | 2020 |